BELBUCA

purdue pharma🇨🇦 Health Canada

Approval Id: 32ca892deff5c2f2
Drug Approval Canada Name: BELBUCA
Product Name: BELBUCA
Status: Cancelled Post Market
Status Date: 2019-05-31
Original Market Date: 2018-01-17
Din: 02465248
Drug Class: Human
Dosage Form: Film, Soluble
Route Of Administration: Buccal
Schedule: Narcotic (CDSA I)
Ahfs: 28:08.12
Atc Original: N02AE01 BUPRENORPHINE
Atc Name: n 02 ae 01
Aig Number: 0142241011
Company Name: purdue pharma
Company Address: 310, 3381 Steeles Avenue East, Toronto, Ontario, Canada, M2H 3S7

BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)

150 MCG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

32ca892deff5c2f2

Type

Standard